-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
May 01, 2013 - However, the
prevalence of depressive symptoms not meeting diagnostic
criteria for depression may be … and treatment,
despite showing improvement in depressive symptoms. … , and although they
suggest an improvement in depressive symptoms with
screening, there are limited … for screening (major
depression alone vs. major and minor depression), and,
if screening is to be performed … symptoms are substantially improved when screening,
diagnosis, and treatment are provided by the same
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-200-comments-post-acs.pdf
November 14, 2017 - Some
published studies used elevated depressive symptoms
rather than depression diagnosis as eligibility … We agree that subthreshold
depressive symptoms can be
important. … who had clinically important
depressive symptoms using a
validated depression scale. … Peer Reviewer #2 Results The description of the efficacy of depression treatments
on depressive symptoms … symptoms in first week after
ACS versus targeting patients with persistently elevated
depressive symptoms
-
effectivehealthcare.ahrq.gov/products/depression-postpartum-screening/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
January 30, 2014 - "
Depression"Scale"scores"(HADS)"(treatment"M=10.63"[2.67]h"waitlist"M=9.56"[3.09])"suggest"
that"participants"experienced"mildKtoKmoderate"depressive"symptoms … $symptoms$(CES"D$M=16$[mild$
depression]S$n=67)$found$a$significant$
reduction$in$depressive$symptoms … $and$anxiety$and$reducing$depressive$symptoms. … $symptoms$
(CES"D$M=16$[mild$
depression]S$n=67)$found$a$
significant$reduction$in$
depressive$symptoms … $Brain$morphometry$changes$and$
depressive$symptoms$after$traumatic$brain$injury.$Psychiatry!
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
May 01, 2013 - Clarify
that EPDS, PDSS and BDI-II are screening
instruments that would detect PP depressive
symptoms … Cheryl Beck's research shows that half of women
with antepartum depressive symptoms go on to
have PPD … symptoms (APDS). … depressive
symptoms and improvement in overall mental
health
[low level evidence, p 42]
-All screening … associated with failure for depressive symptoms to
improve.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-200-post-acs-depression.pdf
November 01, 2017 - Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic … Post-ACS Screening Strategies
A number of screening tools for depression
have been developed. … • Available depression-screening
tools may miss 3 percent of people
with depression, but less than … Hispanic, 33%; African American, 26%
Mean age range: 57.6 to 61.1 years
Depressive disorders: Persistent depressive … symptoms, major or minor depressive disorder, dysthymia, or ICD-10 depressive
disorder (diagnoses 29
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0367_11-08-2010.pdf
January 01, 2010 - and treatment for depression
Comparator(s): Different approaches to screening and treatment, including … approaches, safety and efficacy of treatment,
improvements in depressive symptoms, parenting skills … for depression? … Efficacy and Safety of Screening and
Treatment of Postpartum Depression
Nomination Summary Document … review will be broadened to screening and treatment of
perinatal depression.
-
effectivehealthcare.ahrq.gov/products/depression-postpartum-screening/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
March 29, 2013 - symptoms and added treatment during the time of conception. … Characteristics of diagnosis—whether depression was detected during screening
or not, time of diagnosis … • Subthreshold depressive symptoms which have become the subject of clinical attention. … Speed and duration of response/remission
o Relapse
o Recurrence
o Change in core depressive symptoms … Prevalence of mood symptoms and depressions during pregnancy:
implications for clinical practice and
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Effectiveness Research, AHRQ is interested in innovations
in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … For many patients, single ketamine doses often reduce depressive symptoms
within 2 hours, with improvements … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in
ECT-resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … Of soldiers referred via the Post Deployment Health Assessment
screening process, only 54% follow through … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms with
an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … contraindications for anticholinergic
medication could limit adoption and cautioned that appropriate patient screening … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms with
an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
May 01, 2013 - Perinatal Depression: Prevalence, Screening
Accuracy, and Screening Outcomes. … Perinatal depression: prevalence, screening
accuracy, and screening outcomes. … Maternal depressive symptoms at 2 to 4
months post partum and early parenting practices. … Obstetric, somatic, and demographic risk factors
for postpartum depressive symptoms. … /diagnosis[mesh] OR mass screening[mesh] OR
questionnaires[mesh] OR Interviews as Topic[Mesh] OR Psychometrics
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
April 01, 2011 - Clinicians,
caregivers, and patients lack formal
evidence to guide the timing of depression
screening … KQ2: Screening for Depression After TBI
Content of literature. … The second study128 investigated the effect of citalopram
on depressive symptoms after TBI, using an … Risk factors for depressive symptoms
after mild-to-moderate traumatic brain injury. … Attention and
depressive symptoms in chronic phase after traumatic brain
injury.
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … symptoms in both bipolar
disorder and MDD, although its exact mechanism of action is still unknown … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … Of soldiers referred via the Post Deployment Health Assessment
screening process, only 54% follow through … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … , potentially restoring normal emotional processing and easing depressive symptoms.69
Clinical data … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - Effectiveness Research,
AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … believe that dysfunction in glutamate neurotransmission could play a major role in the
etiology of depressive … symptoms, although its exact mechanism of action is still unknown.
24
Research
suggests that N-methyl-D-aspartate … , investigators concluded, “Within 40 minutes, depressive symptoms
significantly improved in subjects
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
February 15, 2017 - outcomes
• Response or remission of depressive symptoms using
validated continuous or categorical … outcomes
§ Response or remission of
depressive symptoms using
validated continuous or categorical … For depressive symptoms and QOL, it is likely that studies
will use different instruments to measure … depressive symptoms
using a validated
depression scale, and
are within 3 months of an
acute ACS event … /diagnosis"[Mesh] OR mass screening[mesh] OR questionnaires[mesh] OR
Interviews as Topic[Mesh] OR Psychometrics
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Effectiveness Research, AHRQ is interested in innovations
in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … and the severity of certain depressive
symptoms. … symptoms
observed in BPD and MDD.4
Preclinical studies indicate that ketamine’s antidepressant properties … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in
ECT-resistant major